This study is testing an artificial intelligence (AI) program called 'DRISTi' to see how accurately it can screen for Diabetic Retinopathy (DR), an eye condition that can affect people with diabetes. We are looking for about 900 adults, aged 21 or older, who have been diagnosed with diabetes. If you join, ophthalmic images (pictures of your eyes) will be taken. These images will be analyzed by the DRISTi AI software and also by eye specialists. The goal is to compare these results to show that DRISTi can correctly identify different types of Diabetic Retinopathy. This study aims to prove DRISTi is an effective tool for diagnosing DR.

Study design

This is an observational study involving about 900 participants. It is designed to compare the results from an AI program with evaluations from eye specialists.

What's involved

You would need to sign a consent form and have ophthalmic images taken. The diagnostic tests, including image taking, are expected to be completed within 8 hours.

Compensation

Not stated in the trial record.

Follow-up

Your participation involves diagnostic tests completed within 8 hours from your arrival. No further follow-up is specified after this period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.